Regulus Therapeutics Inc (NASDAQ:RGLS)

Monday’s Trading Day
14.59 -2.90 / -16.58%
As of Apr 27
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
14.55 -0.04 / -0.27%
 
Volume: 15.4K
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale11/12/20142,000,000$17.00$34.0M-25.64%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale3/05/201565,614$20.06$1.3M-30.95%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/28/201572,011$17.97$1.3M-17.38%
Gibson Neil W
Chief Scientific Officer
Sale1/28/201571,345$17.98$1.3M-17.38%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/17/201573,929$16.94$1.3M-15.66%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/20/201566,071$16.85$1.1M-15.08%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale4/21/201560,000$17.73$1.1M-17.20%
Alnylam Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+6.11%
Isis Pharmaceuticals Inc
Sale10/22/201457,753$13.91$803.3K+6.11%
Xanthopoulos Kleanthis G
President & Chief Executive Officer
Sale1/29/201533,773$17.77$600.1K-21.47%
Page of 20

To view my watchlist

Not a member yet?

Sign up now for a free account